Literature DB >> 24273482

Hematopoietic Growth Factors in Transfusion Medicine and Cellular Therapy - Part II.

Peter Schlenke1, Andreas Humpe.   

Abstract

Year:  2013        PMID： 24273482      PMCID： PMC3822279          DOI： 10.1159/000354964

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  8 in total

Review 1.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 2.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

3.  Report on Notifications Pursuant to §21 German Transfusion Act for 2008 and 2009.

Authors:  Olaf Henseler; Margarethe Heiden; Birgit Haschberger; Janina Hesse; Rainer Seitz
Journal:  Transfus Med Hemother       Date:  2011-05-13       Impact factor: 3.747

Review 4.  Physiology and pharmacology of erythropoietin.

Authors:  Wolfgang Jelkmann
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

Review 5.  Clinical indications for thrombopoietin and thrombopoietin-receptor agonists.

Authors:  Bernhard Wörmann
Journal:  Transfus Med Hemother       Date:  2013-09-11       Impact factor: 3.747

Review 6.  Impact of erythropoietin on intensive care unit patients.

Authors:  Ines Jelkmann; Wolfgang Jelkmann
Journal:  Transfus Med Hemother       Date:  2013-08-16       Impact factor: 3.747

7.  Promoting Effects of Heparin on ex vivo Expansion of Megakaryocytopoiesis from Human Cord Blood CD34+ Cells.

Authors:  Anne-Marie Maurer; Altay Gezer
Journal:  Transfus Med Hemother       Date:  2013-09-19       Impact factor: 3.747

Review 8.  Impact of interleukin-6 in hematological malignancies.

Authors:  Renate Burger
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.